Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients with Colorectal Cancer

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA

Nature Cancer Summary: ctDNA as an early predictor of therapy response

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection

Gschwend et al Overall survival by circulating tumor DNA status in patients with post-operative muscle-invasive urothelial carcinoma treated

Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.

Dar et al. 2022 AJOG publication

Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome

Dar et al. 2022 AJOG publication

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant

A Novel Donor-Derived Cell-Free DNA Assay for the Detection of Acute Rejection in Heart Transplantation

Association between total cell free DNA and SARS-CoV-2 in Kidney Transplant Patients: A Preliminary Study

Reusing, et al. 2022, Transplant Proceedings

Dd-cfDNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-Kidney Transplantation

Ventura-Aguiar, et al. 2022, Transplantation

Experts Discuss Personalized ctDNA Assays to Predict Immunotherapy Response

BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on pa

Kasi et al. 2021 BMJ Open

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of- opportunity study

Oliva et al. 2021 Journal for ImmunoTherapy of Cancer

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizuma

Yang et al. 2021 Nat Commun

Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of

Loupakis et al. 2021 JCO-PO

Serial ctDNA detection using a personalized, tumor-informed assay in esophageal adenocarcinoma patients following resection

Ococks et al. 2021 Gastroenterology

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in metastatic microsatellite stable colo...

Schneider et al. 2021 Case reports in Onc.

CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer

Taniguchi et al. 2021 Cancer Science